← Back to Patent Explorer
US5204455A Expired / Lapsed US ⏱️ 0.0 years remaining

Monomethoxytrityl protected oligonucleotides bound to a solid support

Assignee: Ionis Pharmaceuticals Inc
•
Filing: 1992-02-10
•
Granted: 1993-04-20
•
Expires: 2012-02-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention describes methods for the production of oligonucleotides under conditions which exploit the desirable characteristics, such as the property of sustaining high degrees of substitution, of functionalized organic polymeric supports while avoiding the sluggish kinetics and low rates of conversion which normally plague syntheses involving such solid supports. By employing the methods and materials disclosed, functionalized support, substituted to a degree of about 250 μmol/g, can be utilized at greater than 98% conversion levels for each sequential nucleotide coupling cycle, to provide unprecedented amounts of isolated oligonucleotide per gram of solid support.

Inventors

  • 👤 Brian C. Froehler
  • 👤 Kenneth M. Kent
  • 👤 Sylvia Wu

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-01 04:07
CPC Classifications
C; C07; C07H; C07H21/00; B; B01; B01J; B01J19/00; B01J19/0046; C07H19/00; C07H19/02; C07H19/04; C07H19/06; C07H19/10; C07H19/16; C07H19/20; B01J2219/00; B01J2219/00274; B01J2219/00277; B01J2219/00279; B01J2219/00281; B01J2219/00286; B01J2219/00497; B01J2219/00583; B01J2219/0059; B01J2219/00596; B01J2219/00718; B01J2219/0072; B01J2219/00722; C40; C40B; C40B40/00; C40B40/04; C40B40/06; C40B60/00; C40B60/14

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 43 words
An oligonucleotide H-phosphonate, each internucleotide linkage of which contains an H-phosphonate moiety, which olionucleotide has a 5'-hydroxyl end and a 3'-hydroxyl end, one of which ends is bound to a solid support while the remaining end is blocked by a monomethoxytrityl protecting group.
Claim 2
Dependent Claim 43 words
An oligonucleotide H-phosphonate, each internucleotide linkage of which contains an H-phosphonate moiety, which olionucleotide has a 5'-hydroxyl end and a 3'-hydroxyl end, one of which ends is bound to a solid support while the remaining end is blocked by a monomethoxytrityl protecting group.
Claim 3
Dependent Claim 28 words
The oligonucleotide of claim 1 in which the 3'-hydroxyl end is bound to said solid support while the 5'-hydroxyl end is blocked by said monomethoxytrityl protecting the group.
Claim 4
Dependent Claim 28 words
The oligonucleotide of claim 1 in which the 5'-hydroxyl end is bound to said solid support while the 3'-hydroxyl end is blocked by said monomethoxytrityl protecting the group.
Claim 5
Dependent Claim 16 words
The oligonucleotide of claim 1 in which said solid support comprises a swellable polymeric organic support.
Claim 6
Dependent Claim 19 words
The oligonucleotide of claim 4 in which said swellable polymeric organic support is a polymer or copolymer of styrene.
Claim 7
Dependent Claim 25 words
The oligonucleotide of claim 4 in which said swellable polymeric organic solid support is selected form the group consisting of poly(styrene-co-divinylbenzene), poly(styrene-co-butadiene), poly(dimethylacrylamide-co-ethylenebisacrylamide), and poly(acryloylmorpholide).
Claim 8
Dependent Claim 27 words
The oligonucleotide of claim 5 in which said polymer or copolymer of styrene includes reactive functional groups selected from the group consisting of aminomethyl, hydroxymethyl, or carboxymethyl.
Claim 9
Dependent Claim 17 words
The oligonucleotide of claim 4 in which said swellable polymeric organic solid support is an aminomethylated poly(styrene-co-divinylbenzene).
Claim 10
Dependent Claim 14 words
The oligonucleotide of claim 1 which comprises from 2 to about 30 base monomers.
Claim 11
Dependent Claim 12 words
The oligonucleotide of claim 1 which comprises 30 or more base monomers.

References Cited (Backward Citations)

US4415732A Cited
EP0155950A1 Cited
EP0219342A2 Cited
US5047524A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1996-04-19 1996-10-19 1997-04-20 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2000-04-19 2000-10-19 2001-04-20 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2004-04-19 2004-10-19 2005-04-20 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag